CYTK: Cash Flow for Cytokinetics, Incorporated

PERIOD ENDING	30-Sep-09	30-Jun-09	31-Mar-09	31-Dec-08
Net Income	(8,201)	55,959	(10,685)	(10,856)

Operating Activities, Cash Flows Provided By or Used In
Depreciation	501	511	515	563
Adjustments To Net Income	1,249	2,874	1,180	984
Changes In Accounts Receivables	(4,021)	(516)	214	(153)
Changes In Liabilities	(939)	(20,077)	(3,626)	(3,845)
Changes In Inventories	-	-	-	-
Changes In Other Operating Activities	(156)	(634)	614	235

Total Cash Flow From Operating Activities	(11,567)	38,117	(11,788)	(13,072)

Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures	(70)	(50)	(219)	(20)
Investments	(47,074)	(14,042)	(572)	(15,031)
Other Cashflows from Investing Activities	570	38	542	-

Total Cash Flows From Investing Activities	(47,650)	(14,054)	(249)	(15,051)

Financing Activities, Cash Flows Provided By or Used In
Dividends Paid	-	-	-	-
Sale Purchase of Stock	7,058	6,256	6,880	208
Net Borrowings	(9,158)	6,224	11,827	(902)
Other Cash Flows from Financing Activities	-	-	-	-

Total Cash Flows From Financing Activities	(2,100)	12,480	18,707	(694)
Effect Of Exchange Rate Changes	-	-	-	-

Change In Cash and Cash Equivalents	($61,317)	$36,543	$6,670	($28,817)

Add to Portfolio

Set Alert

Email to a Friend

•	Sector Analysis

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More